Finance

Lists
2CG:FRA
Nanosphere Health Sciences Inc
€0.0080
0.00%
(0.00) 1D
Oct 19, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 2CG...
Open
€0.01
High
€0.01
Low
€0.01
Mkt. cap
204.84K
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.03
52-wk low
€0.00
No. of employees
5
Open
€0.01
High
€0.01
Low
€0.01
Mkt. cap
204.84K
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.03
52-wk low
€0.00
No. of employees
5
News stories
From web sources and news partners
About Nanosphere Health Sciences Inc
CEO-
Employees5
Founded2005
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
50.43K
39.37K
42.71K
42.71K
Operating expense
50.43K
39.37K
42.71K
42.71K
Total operating expenses
50.43K
39.37K
42.71K
42.71K
Operating income
-50.43K
-39.37K
-42.71K
-42.71K
Other non operating income
-1.93K
-9.58K
-2.31K
-2.31K
EBT including unusual items
-9.54K
38.70K
-47.20K
-47.20K
EBT excluding unusual items
-11.34K
-51.28K
-47.20K
-47.20K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.54K
38.70K
-47.20K
-47.20K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.13K
-2.15K
-1.66K
-1.66K
Net interest expenses
-1.13K
-2.15K
-1.66K
-1.66K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps